JPH1031018A - Reduced form nicotinamide coenzyme measuring reagent and measuring method and measuring test piece using it - Google Patents
Reduced form nicotinamide coenzyme measuring reagent and measuring method and measuring test piece using itInfo
- Publication number
- JPH1031018A JPH1031018A JP18497796A JP18497796A JPH1031018A JP H1031018 A JPH1031018 A JP H1031018A JP 18497796 A JP18497796 A JP 18497796A JP 18497796 A JP18497796 A JP 18497796A JP H1031018 A JPH1031018 A JP H1031018A
- Authority
- JP
- Japan
- Prior art keywords
- reduced nicotinamide
- measuring
- coenzyme
- reagent
- nicotinamide coenzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 title claims abstract description 70
- 239000005515 coenzyme Substances 0.000 title claims abstract description 43
- 229960003966 nicotinamide Drugs 0.000 title claims abstract description 35
- 235000005152 nicotinamide Nutrition 0.000 title claims abstract description 35
- 239000011570 nicotinamide Substances 0.000 title claims abstract description 35
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 23
- 238000000034 method Methods 0.000 title claims description 27
- 125000005504 styryl group Chemical group 0.000 claims abstract description 29
- 108091006149 Electron carriers Proteins 0.000 claims abstract description 18
- 239000007788 liquid Substances 0.000 claims abstract description 11
- 239000000126 substance Substances 0.000 claims abstract description 9
- 238000002835 absorbance Methods 0.000 claims abstract description 4
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 claims description 38
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 claims description 32
- 238000006243 chemical reaction Methods 0.000 claims description 15
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 claims description 7
- 210000004369 blood Anatomy 0.000 claims description 4
- 239000008280 blood Substances 0.000 claims description 4
- 210000002700 urine Anatomy 0.000 claims description 4
- 206010003445 Ascites Diseases 0.000 claims description 2
- 208000002151 Pleural effusion Diseases 0.000 claims description 2
- 210000001185 bone marrow Anatomy 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims description 2
- 210000003296 saliva Anatomy 0.000 claims description 2
- 210000004243 sweat Anatomy 0.000 claims description 2
- 210000001138 tear Anatomy 0.000 claims description 2
- 238000005259 measurement Methods 0.000 abstract description 34
- NBGFRWYAFLAYMC-UHFFFAOYSA-M (2e,4z)-5-[4-(dimethylamino)phenyl]-2-(3-ethyl-1,3-benzothiazol-3-ium-2-yl)penta-2,4-dienenitrile;iodide Chemical compound [I-].S1C2=CC=CC=C2[N+](CC)=C1C(\C#N)=C\C=C/C1=CC=C(N(C)C)C=C1 NBGFRWYAFLAYMC-UHFFFAOYSA-M 0.000 abstract description 2
- 239000000049 pigment Substances 0.000 abstract 4
- 239000000975 dye Substances 0.000 description 28
- 239000000523 sample Substances 0.000 description 14
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 12
- -1 riboflavin Natural products 0.000 description 10
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 8
- XJLXINKUBYWONI-NNYOXOHSSA-N NADP zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-NNYOXOHSSA-N 0.000 description 8
- 238000011088 calibration curve Methods 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine group Chemical group N1=CCC2=CC=CC=C12 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 229960005070 ascorbic acid Drugs 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 235000010323 ascorbic acid Nutrition 0.000 description 5
- 239000011668 ascorbic acid Substances 0.000 description 5
- 229950006238 nadide Drugs 0.000 description 5
- 230000009257 reactivity Effects 0.000 description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- 101710088194 Dehydrogenase Proteins 0.000 description 3
- 238000000691 measurement method Methods 0.000 description 3
- 239000005020 polyethylene terephthalate Substances 0.000 description 3
- 229920000139 polyethylene terephthalate Polymers 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 125000003831 tetrazolyl group Chemical group 0.000 description 3
- LBUJPTNKIBCYBY-UHFFFAOYSA-N 1,2,3,4-tetrahydroquinoline Chemical compound C1=CC=C2CCCNC2=C1 LBUJPTNKIBCYBY-UHFFFAOYSA-N 0.000 description 2
- AIGNCQCMONAWOL-UHFFFAOYSA-N 1,3-benzoselenazole Chemical group C1=CC=C2[se]C=NC2=C1 AIGNCQCMONAWOL-UHFFFAOYSA-N 0.000 description 2
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 2
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 2
- QMHIMXFNBOYPND-UHFFFAOYSA-N 4-methylthiazole Chemical compound CC1=CSC=N1 QMHIMXFNBOYPND-UHFFFAOYSA-N 0.000 description 2
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical group C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 125000002843 carboxylic acid group Chemical group 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 125000000547 substituted alkyl group Chemical group 0.000 description 2
- 125000000542 sulfonic acid group Chemical group 0.000 description 2
- CBDKQYKMCICBOF-UHFFFAOYSA-N thiazoline Chemical compound C1CN=CS1 CBDKQYKMCICBOF-UHFFFAOYSA-N 0.000 description 2
- UUJOCRCAIOAPFK-UHFFFAOYSA-N 1,3-benzoselenazol-5-ol Chemical compound OC1=CC=C2[se]C=NC2=C1 UUJOCRCAIOAPFK-UHFFFAOYSA-N 0.000 description 1
- CDLWXLGNBWQWHF-UHFFFAOYSA-N 1,3-benzothiazole-5,6-diol Chemical compound C1=C(O)C(O)=CC2=C1SC=N2 CDLWXLGNBWQWHF-UHFFFAOYSA-N 0.000 description 1
- RBIZQDIIVYJNRS-UHFFFAOYSA-N 1,3-benzothiazole-5-carboxylic acid Chemical compound OC(=O)C1=CC=C2SC=NC2=C1 RBIZQDIIVYJNRS-UHFFFAOYSA-N 0.000 description 1
- SAHAKBXWZLDNAA-UHFFFAOYSA-N 1,3-benzoxazol-6-ol Chemical compound OC1=CC=C2N=COC2=C1 SAHAKBXWZLDNAA-UHFFFAOYSA-N 0.000 description 1
- ODIRBFFBCSTPTO-UHFFFAOYSA-N 1,3-selenazole Chemical group C1=C[se]C=N1 ODIRBFFBCSTPTO-UHFFFAOYSA-N 0.000 description 1
- MASUWVVNWALEEM-UHFFFAOYSA-M 1-methoxy-5-methylphenazin-5-ium;methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC=C2N=C3C(OC)=CC=CC3=[N+](C)C2=C1 MASUWVVNWALEEM-UHFFFAOYSA-M 0.000 description 1
- VMNRNUNYBVFVQI-UHFFFAOYSA-N 10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one Chemical compound C1CC2CC(=O)CCC2(C)C2C1C1CCCC1(C)CC2 VMNRNUNYBVFVQI-UHFFFAOYSA-N 0.000 description 1
- HHACVMFSEAZPMT-UHFFFAOYSA-N 2-ethyl-1,3-benzothiazol-3-ium;iodide Chemical compound [I-].C1=CC=C2SC(CC)=[NH+]C2=C1 HHACVMFSEAZPMT-UHFFFAOYSA-N 0.000 description 1
- IYUBCLHILARKQB-UHFFFAOYSA-N 2-sulfonylbenzimidazole Chemical compound C1=CC=CC2=NC(=S(=O)=O)N=C21 IYUBCLHILARKQB-UHFFFAOYSA-N 0.000 description 1
- ODKHOKLXMBWVOQ-UHFFFAOYSA-N 4,5-diphenyl-1,3-oxazole Chemical compound O1C=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 ODKHOKLXMBWVOQ-UHFFFAOYSA-N 0.000 description 1
- BGTVICKPWACXLR-UHFFFAOYSA-N 4,5-diphenyl-1,3-thiazole Chemical compound S1C=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 BGTVICKPWACXLR-UHFFFAOYSA-N 0.000 description 1
- RUKJCCIJLIMGEP-ONEGZZNKSA-N 4-dimethylaminocinnamaldehyde Chemical compound CN(C)C1=CC=C(\C=C\C=O)C=C1 RUKJCCIJLIMGEP-ONEGZZNKSA-N 0.000 description 1
- PUMREIFKTMLCAF-UHFFFAOYSA-N 4-methyl-1,3-oxazole Chemical compound CC1=COC=N1 PUMREIFKTMLCAF-UHFFFAOYSA-N 0.000 description 1
- BJATXNRFAXUVCU-UHFFFAOYSA-N 4-methyl-1,3-selenazole Chemical compound CC1=C[se]C=N1 BJATXNRFAXUVCU-UHFFFAOYSA-N 0.000 description 1
- KXCQDIWJQBSUJF-UHFFFAOYSA-N 4-phenyl-1,3-thiazole Chemical compound S1C=NC(C=2C=CC=CC=2)=C1 KXCQDIWJQBSUJF-UHFFFAOYSA-N 0.000 description 1
- ODSGKKPRKQLYDA-UHFFFAOYSA-N 5-(trifluoromethyl)-1,3-benzothiazole Chemical compound FC(F)(F)C1=CC=C2SC=NC2=C1 ODSGKKPRKQLYDA-UHFFFAOYSA-N 0.000 description 1
- DUMYZVKQCMCQHJ-UHFFFAOYSA-N 5-chloro-1,3-benzoselenazole Chemical compound ClC1=CC=C2[se]C=NC2=C1 DUMYZVKQCMCQHJ-UHFFFAOYSA-N 0.000 description 1
- YTSFYTDPSSFCLU-UHFFFAOYSA-N 5-chloro-1,3-benzothiazole Chemical compound ClC1=CC=C2SC=NC2=C1 YTSFYTDPSSFCLU-UHFFFAOYSA-N 0.000 description 1
- VWMQXAYLHOSRKA-UHFFFAOYSA-N 5-chloro-1,3-benzoxazole Chemical compound ClC1=CC=C2OC=NC2=C1 VWMQXAYLHOSRKA-UHFFFAOYSA-N 0.000 description 1
- NIFNXGHHDAXUGO-UHFFFAOYSA-N 5-phenyl-1,3-benzoxazole Chemical compound C=1C=C2OC=NC2=CC=1C1=CC=CC=C1 NIFNXGHHDAXUGO-UHFFFAOYSA-N 0.000 description 1
- AHOIGFLSEXUWNV-UHFFFAOYSA-N 6-methoxy-1,3-benzothiazole Chemical compound COC1=CC=C2N=CSC2=C1 AHOIGFLSEXUWNV-UHFFFAOYSA-N 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- KIWBPDUYBMNFTB-UHFFFAOYSA-N Ethyl hydrogen sulfate Chemical compound CCOS(O)(=O)=O KIWBPDUYBMNFTB-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 101000892220 Geobacillus thermodenitrificans (strain NG80-2) Long-chain-alcohol dehydrogenase 1 Proteins 0.000 description 1
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- PLXBWHJQWKZRKG-UHFFFAOYSA-N Resazurin Chemical compound C1=CC(=O)C=C2OC3=CC(O)=CC=C3[N+]([O-])=C21 PLXBWHJQWKZRKG-UHFFFAOYSA-N 0.000 description 1
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- KXNQKOAQSGJCQU-UHFFFAOYSA-N benzo[e][1,3]benzothiazole Chemical compound C1=CC=C2C(N=CS3)=C3C=CC2=C1 KXNQKOAQSGJCQU-UHFFFAOYSA-N 0.000 description 1
- WMUIZUWOEIQJEH-UHFFFAOYSA-N benzo[e][1,3]benzoxazole Chemical compound C1=CC=C2C(N=CO3)=C3C=CC2=C1 WMUIZUWOEIQJEH-UHFFFAOYSA-N 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- NJDNXYGOVLYJHP-UHFFFAOYSA-L disodium;2-(3-oxido-6-oxoxanthen-9-yl)benzoate Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=CC(=O)C=C2OC2=CC([O-])=CC=C21 NJDNXYGOVLYJHP-UHFFFAOYSA-L 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 150000004694 iodide salts Chemical class 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- DZFWNZJKBJOGFQ-UHFFFAOYSA-N julolidine Chemical compound C1CCC2=CC=CC3=C2N1CCC3 DZFWNZJKBJOGFQ-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N methanesulfonic acid Substances CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N p-toluenesulfonic acid Substances CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Chemical compound [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- HSSLDCABUXLXKM-UHFFFAOYSA-N resorufin Chemical compound C1=CC(=O)C=C2OC3=CC(O)=CC=C3N=C21 HSSLDCABUXLXKM-UHFFFAOYSA-N 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、還元型ニコチンア
ミド補酵素の測定用試薬およびそれを用いた測定方法並
びに測定用試験片に関するものである。The present invention relates to a reagent for measuring reduced nicotinamide coenzyme, a measuring method using the same, and a test strip for measurement.
【0002】[0002]
【従来の技術】還元型ニコチンアミド補酵素、すなわ
ち、還元型ニコチンアミドアデニンジヌクレオチド(N
ADH)および還元型ニコチンアミドアデニンジヌクレ
オチドホスフェート(NADPH)は、生体内での酸化
還元反応に関与する補酵素である。したがって、還元型
ニコチンアミド補酵素を測定することにより、これに関
連する酵素または基質の測定ができる。2. Description of the Related Art Reduced nicotinamide coenzyme, that is, reduced nicotinamide adenine dinucleotide (N
ADH) and reduced nicotinamide adenine dinucleotide phosphate (NADPH) are coenzymes involved in redox reactions in vivo. Therefore, by measuring the reduced nicotinamide coenzyme, an enzyme or a substrate related thereto can be measured.
【0003】従来から、NADHおよびNADPHの測
定方法としては、以下のような方法が知られている。 (1)NADHおよびNADPHの有する紫外部の吸収
または蛍光を直接測定する方法。Conventionally, the following methods are known as methods for measuring NADH and NADPH. (1) A method of directly measuring the ultraviolet absorption or fluorescence of NADH and NADPH.
【0004】(2)触媒の存在下、NADHおよびNA
DPHとレサズリンの反応によって生成したレゾルフィ
ンの蛍光を測定する方法。 (3)電子伝達体の存在下、NADHおよびNADPH
とNTBやMTT等のテトラゾリウム塩とを反応させて
ホルマザン色素を生成し、その可視部の吸収を測定する
方法。(2) NADH and NA in the presence of a catalyst
A method for measuring the fluorescence of resorufin generated by the reaction between DPH and resazurin. (3) NADH and NADPH in the presence of an electron carrier
A formazan dye by reacting the compound with a tetrazolium salt such as NTB or MTT, and measuring the absorption in the visible region.
【0005】[0005]
【発明が解決しようとする課題】しかしながら、従来の
測定方法は、以下の問題を有する。まず、前記紫外部の
吸収および蛍光を測定する方法(1)は、尿等を測定対
象とする場合には、紫外部に吸収を有するまたは蛍光を
有する共存物質、例えば、リボフラビン等のビタミンB
2 剤、フルオレッセインナトリウム等の蛍光造影剤によ
って妨害を受ける。この問題は、前記(2)の方法も同
様である。However, the conventional measuring method has the following problems. First, in the method (1) for measuring ultraviolet absorption and fluorescence, when urine or the like is to be measured, a coexisting substance having ultraviolet absorption or fluorescence, for example, vitamin B such as riboflavin, etc.
Disturbed by two agents, a fluorescent contrast agent such as sodium fluorescein. This problem is the same in the method (2).
【0006】また、前記テトラゾリウム塩を発色剤とし
て用いる方法(3)は、試料中に共存するアスコルビン
酸、ビリルビン等の還元性物質による影響で、ブランク
発色を生じるという欠点がある。The method (3) in which the tetrazolium salt is used as a coloring agent has a disadvantage that blank coloring is caused by the influence of reducing substances such as ascorbic acid and bilirubin which coexist in the sample.
【0007】この他に、NADHを用いずに生体試料中
の成分を測定する方法として、酸化酵素を用いる方法が
あるが、前記テトラゾリウム塩を用いる方法(3)と同
様に、試料中に共存するアスコルビン酸、ビリルビン等
の還元性物質の影響を受けて発色が阻害されるという欠
点がある。[0007] As another method for measuring components in a biological sample without using NADH, there is a method using an oxidase. However, similar to the method (3) using a tetrazolium salt, the method coexists in the sample. There is a drawback that coloring is inhibited by the influence of reducing substances such as ascorbic acid and bilirubin.
【0008】さらに、NADHおよびNADPHの測定
方法において、測定操作等の観点から乾式測定の実現が
求められている。本発明は、前記従来の問題を解決し、
紫外部に吸収若しくは蛍光を有する共存物質および還元
性物質の影響を受けず、乾式測定が可能な還元型ニコチ
ンアミド補酵素の測定用試薬およびそれを用いた測定方
法並びに測定用試験片の提供を目的とする。Further, in the method of measuring NADH and NADPH, realization of dry measurement is required from the viewpoint of measuring operation and the like. The present invention solves the above-mentioned conventional problems,
Provided is a reagent for measuring reduced nicotinamide coenzyme which is not affected by a coexisting substance having ultraviolet absorption or fluorescence and a reducing substance and can be dry-measured, a measurement method using the same, and a test piece for measurement. Aim.
【0009】[0009]
【課題を解決するための手段】前記目的を達成するため
に、本発明の還元型ニコチンアミド補酵素の測定用試薬
は、前記の式[化1]で示されるスチリル色素を含有す
る。In order to achieve the above object, a reagent for measuring a reduced nicotinamide coenzyme of the present invention contains a styryl dye represented by the above formula [Formula 1].
【0010】この特殊なスチリル色素は、電子伝達体の
存在下で、NADHおよびNADPHの少なくとも一方
と作用させると、紫外部に蛍光等を有する共存物質およ
びアスコルビン酸、ビリルビン等の影響を受けず、高い
選択性でNADH等を測定できる。具体的には、10-6
M以下の微量のNADH等の測定が可能である。さら
に、この特殊なスチリル色素は、乾式測定に供しても高
い反応性を失うことがない。このように、本発明にかか
るスチリル色素は、高い反応性を有し、乾式測定に適用
できるが、これは、スチリル色素の分子構造中のメチン
鎖に酸性官能基が付加されているためと推察される。When this special styryl dye is allowed to act on at least one of NADH and NADPH in the presence of an electron carrier, it is not affected by a coexisting substance having fluorescence or the like in the ultraviolet and ascorbic acid, bilirubin, etc. NADH and the like can be measured with high selectivity. Specifically, 10 -6
It is possible to measure trace amounts of NADH or less. Furthermore, this special styryl dye does not lose high reactivity even when subjected to dry measurement. As described above, the styryl dye according to the present invention has high reactivity and can be applied to dry measurement.This is presumed to be because an acidic functional group is added to the methine chain in the molecular structure of the styryl dye. Is done.
【0011】本発明の測定用試薬において、電子伝達体
を含有してもよい。また、この電子伝達体として、ジア
ホラーゼを用いることが好ましい。また、本発明の測定
方法において、還元型ニコチンアミド補酵素は、通常、
還元型ニコチンアミドアデニンジヌクレオチドおよび還
元型ニコチンアミドアデニンジヌクレオチドホスフェー
トの少なくとも一方の補酵素である。[0011] The measuring reagent of the present invention may contain an electron carrier. It is preferable to use diaphorase as this electron carrier. In the measurement method of the present invention, the reduced nicotinamide coenzyme is usually
It is a coenzyme of at least one of reduced nicotinamide adenine dinucleotide and reduced nicotinamide adenine dinucleotide phosphate.
【0012】つぎに、本発明の還元型ニコチンアミド補
酵素の測定方法は、電子伝達体の存在下、前記本発明の
還元型ニコチンアミド補酵素の測定用試薬中のスチリル
色素と液体試料に含まれる還元型ニコチンアミド補酵素
とを反応させて前記スチリル色素を褪色させ、可視部の
吸光度の変化を測定する。Next, the method for measuring a reduced nicotinamide coenzyme of the present invention comprises the step of including a styryl dye in a reagent for measuring a reduced nicotinamide coenzyme of the present invention and a liquid sample in the presence of an electron carrier. The styryl dye is discolored by reacting with the reduced nicotinamide coenzyme to be measured, and the change in absorbance in the visible region is measured.
【0013】本発明の測定方法において、前記液体試料
としては、例えば、血液、尿、骨髄液、リコール、胸
水、腹水、汗、涙または唾液があげられる。本発明の測
定方法において、電子伝達体としてジアホラーゼを用い
ることが好ましく、この場合、通常、前記スチリル色素
0.1〜10.0molに対しジアホラーゼ0.12〜
1.20mkatの割合で用いる。In the measuring method of the present invention, examples of the liquid sample include blood, urine, bone marrow fluid, recall, pleural effusion, ascites, sweat, tears, and saliva. In the measurement method of the present invention, it is preferable to use diaphorase as the electron carrier. In this case, usually, diaphorase 0.12 to styrol dye 0.1 to 10.0 mol is used.
Used at a rate of 1.20 mkat.
【0014】本発明の測定方法において、還元型ニコチ
ンアミド補酵素は、通常、還元型ニコチンアミドアデニ
ンジヌクレオチドおよび還元型ニコチンアミドアデニン
ジヌクレオチドホスフェートの少なくとも一方の補酵素
である。In the measuring method of the present invention, the reduced nicotinamide coenzyme is usually at least one coenzyme of reduced nicotinamide adenine dinucleotide and reduced nicotinamide adenine dinucleotide phosphate.
【0015】つぎに、本発明の還元型ニコチンアミド補
酵素の測定用試験片は、前記本発明の電子伝達体を含有
する還元型ニコチンアミド補酵素の測定用試薬を担体に
付着させたものである。この測定用試験片は、例えば、
前記本発明の電子伝達体を含有する測定用試薬を担体に
含浸する方法、若しくは、前記試薬を担体に塗布、印刷
または噴霧することにより作製できる。Next, the test piece for measuring reduced nicotinamide coenzyme of the present invention is obtained by adhering the reagent for measuring reduced nicotinamide coenzyme containing the electron carrier of the present invention to a carrier. is there. This test piece for measurement, for example,
It can be produced by a method of impregnating a carrier with the measurement reagent containing the electron carrier of the present invention, or by applying, printing or spraying the reagent on the carrier.
【0016】[0016]
【発明の実施の形態】前記の式[化1]で表されるスチ
リル色素において、Zによって形成される複素環の具体
例としては、チアゾール系の環(例えば、チアゾール、
4−メチルチアゾール、4−フェニルチアゾール、4,
5−ジフェニルチアゾール)、ベンゾチアゾール系の環
(例えば、ベンゾチアゾール、5−クロロベンゾチアゾ
ール、6−メトキシベンゾチアゾール、5−トリフルオ
ロメチルベンゾチアゾール、5−カルボキシベンゾチア
ゾール、5,6−ジヒドロキシベンゾチアゾール)、ナ
フトチアゾール系の環(例えば、α−ナフトチアゾー
ル、β−ナフトチアゾール、5−ヒドロキシ−β−ナフ
トチアゾール)、オキサゾール系の環(例えば、4−メ
チルオキサゾール、4,5−ジフェニルオキサゾー
ル)、ベンゾオキサゾール系の環(例えば、ベンゾオキ
サゾール、6−ヒドロキシベンゾオキサゾール、5−ク
ロロベンゾオキサゾール、5−フェニルベンゾオキサゾ
ール)、ナフトオキサゾール系の環(例えば、α−ナフ
トオキサゾール、β−ナフトオキサゾール)、セレナゾ
ール系の環(例えば、4−メチルセレナゾール)、ベン
ゾセレナゾール系の環(例えば、ベンゾセレナゾール、
5−ヒドロキシベンゾセレナゾール、5−クロロベンゾ
セレナゾール)、チアゾリン系の環(例えば、チアゾリ
ン)、2−ピリジン系の環(例えば、2−ピリジン、5
−メトキシ−2−ピリジン)、4−ピリジン系の環(例
えば、4−ピリジン、3−クロロ−4−ピリジン)、2
−キノリン系の環(例えば、2−キノリン、6−ヒドロ
キシ−2−キノリン、6−エトキシ−2−キノリン)、
4−キノリン系の環(例えば、4−キノリン、6−メト
キシ−4−キノリン、6−クロロ−4−キノリン)、1
−イソキノリン系の環(1−イソキノリン)、3,3−
ジアルキルインドレニン系の環(例えば、3,3−ジメ
チルインドレニン、5−クロロ−3,3−ジメチルイン
ドレニン、5−カルボキシ−3,3−ジメチルインドレ
ニン、5−スルホキシ−3,3−ジメチルインドレニ
ン、3−シクロヘキシルインドレニン、5−メチルスル
ホニル−3,3−ジメチルインドレニン)、3,3−ジ
アルキルベンゾインドレニン系の環(例えば、3,3−
ジメチル−α−ベンゾインドレニン、3,3−ジメチル
−β−ベンゾインドレニン)、ベンゾイミダゾール系の
環(例えば、ベンゾイミダゾール、1−アルキル−5,
6−ジクロロベンゾイミダゾール、1−アルキル−5−
スルホニルベンゾイミダゾール、1−アルキル−5−ト
リフルオロメチルベンゾイミダゾール)の核含有環を含
む環等の、5員および6員のヘテロ環が挙げられる。BEST MODE FOR CARRYING OUT THE INVENTION In the styryl dye represented by the above formula [1], specific examples of the heterocyclic ring formed by Z include a thiazole ring (for example, thiazole,
4-methylthiazole, 4-phenylthiazole, 4,
5-diphenylthiazole), benzothiazole-based ring (for example, benzothiazole, 5-chlorobenzothiazole, 6-methoxybenzothiazole, 5-trifluoromethylbenzothiazole, 5-carboxybenzothiazole, 5,6-dihydroxybenzothiazole ), Naphthothiazole-based rings (eg, α-naphthothiazole, β-naphthothiazole, 5-hydroxy-β-naphthothiazole), oxazole-based rings (eg, 4-methyloxazole, 4,5-diphenyloxazole), Benzoxazole-based rings (eg, benzoxazole, 6-hydroxybenzoxazole, 5-chlorobenzoxazole, 5-phenylbenzoxazole), naphthoxazole-based rings (eg, α-naphthoxazole, β-naphtho) Oxazole), selenazole ring (eg, 4-methyl selenazole), benzo selenazole ring (eg, benzo selenazole,
5-hydroxybenzoselenazole, 5-chlorobenzoselenazole), thiazoline-based ring (eg, thiazoline), 2-pyridine-based ring (eg, 2-pyridine, 5
-Methoxy-2-pyridine), a 4-pyridine ring (eg, 4-pyridine, 3-chloro-4-pyridine),
-Quinoline-based rings (eg, 2-quinoline, 6-hydroxy-2-quinoline, 6-ethoxy-2-quinoline),
4-quinoline-based rings (eg, 4-quinoline, 6-methoxy-4-quinoline, 6-chloro-4-quinoline), 1
An isoquinoline ring (1-isoquinoline), 3,3-
Dialkyl indolenine ring (for example, 3,3-dimethyl indolenine, 5-chloro-3,3-dimethyl indolenine, 5-carboxy-3,3-dimethyl indolenine, 5-sulfoxy-3,3-dimethyl Indolenine, 3-cyclohexyl indolenine, 5-methylsulfonyl-3,3-dimethylindolenine), 3,3-dialkylbenzoindolenine ring (for example, 3,3-
Dimethyl-α-benzoindolenine, 3,3-dimethyl-β-benzoindolenine), benzimidazole-based ring (for example, benzimidazole, 1-alkyl-5,
6-dichlorobenzimidazole, 1-alkyl-5
5- and 6-membered heterocycles such as a ring containing a nucleus-containing ring of sulfonylbenzimidazole, 1-alkyl-5-trifluoromethylbenzimidazole).
【0017】R1 の具体例としては、メチル基、エチル
基、イソプロピル基、ブチル基、イソアミル基、オクチ
ル基、2−エチルヘキシル基、ドデシル基等のアルキル
基、これらの置換アルキル基が挙げられる。置換アルキ
ル基の置換基の具体例としては、塩素、臭素、フッ素及
びヨウ素等のハロゲン原子、アリール基(例えば、フェ
ニル基、ナフチル基)、アルコキシ基、水酸基、カルボ
ン酸基、スルホン酸基等が挙げられる。Specific examples of R 1 include alkyl groups such as methyl group, ethyl group, isopropyl group, butyl group, isoamyl group, octyl group, 2-ethylhexyl group and dodecyl group, and substituted alkyl groups thereof. Specific examples of the substituent of the substituted alkyl group include a halogen atom such as chlorine, bromine, fluorine and iodine, an aryl group (for example, a phenyl group or a naphthyl group), an alkoxy group, a hydroxyl group, a carboxylic acid group, a sulfonic acid group and the like. No.
【0018】R´、R´´によって置換されたベンゼン
環の具体例としては、4−ジメチルアミノベンゼン、
1,2,3,4−テトラヒドロキノリン、ユロリジン等
が挙げられる。Specific examples of the benzene ring substituted by R ′ and R ″ include 4-dimethylaminobenzene,
1,2,3,4-tetrahydroquinoline, julolidine and the like.
【0019】Xの具体例としては、塩化物、臭素化物、
フッ素化物およびヨウ素化物等のハロゲン化物があり、
例えば、メタンスルホン酸イオン、p−トルエンスルホ
ン酸イオン等のスルホン酸イオン、メチル硫酸イオンお
よびエチル硫酸イオン等の硫酸イオンが挙げられ、その
他、過塩素酸イオン、硝酸イオン等のイオンも例示でき
る。なお、R1 の置換基がカルボン酸基またはスルホン
酸基等の酸基を含んでおり、スチリル色素が分子内塩を
形成する場合には、Xは必要でない。Specific examples of X include chloride, bromide,
There are halides such as fluorides and iodides,
Examples thereof include sulfonic acid ions such as methanesulfonic acid ion and p-toluenesulfonic acid ion, and sulfate ions such as methyl sulfate ion and ethyl sulfate ion, and also include ions such as perchlorate ion and nitrate ion. When the substituent of R 1 contains an acid group such as a carboxylic acid group or a sulfonic acid group, and the styryl dye forms an inner salt, X is not necessary.
【0020】本発明にかかるスチリル色素の具体例とし
ては、下記の式(化2)に示す2−[1−シアノ−4−
(4−ジメチルアミノフェニル)−1,3−ブタジエニ
ル]−3−エチルベンゾチアゾリウム アイオダイドが
あげられる。As a specific example of the styryl dye according to the present invention, 2- [1-cyano-4-
(4-dimethylaminophenyl) -1,3-butadienyl] -3-ethylbenzothiazolium iodide.
【0021】[0021]
【化2】 Embedded image
【0022】つぎに、本発明にかかるスチリル色素の製
造の一例について説明する。スチリル色素として、2−
[4−(4−ジメチルアミノ)フェニル−1,3−ブタ
ジエニル−1−シアノ]−3−エチルベンゾチアゾリウ
ム アイオダイドを合成した。Next, an example of the production of the styryl dye according to the present invention will be described. As styryl dyes, 2-
[4- (4-Dimethylamino) phenyl-1,3-butadienyl-1-cyano] -3-ethylbenzothiazolium iodide was synthesized.
【0023】すなわち、まず、2−シアノメチル−3−
エチルベンゾチアゾリウム アイオダイド1.2gおよ
び4−ジメチルアミノシンナムアルデヒド0.7gを1
0mlの無水酢酸に加え混合する。この混合物を、80
℃のウオーターバスで2〜3分間加熱すると、針状結晶
が析出する。さらに、20分間加熱し、析出した針状結
晶を吸引ろ過して分離し、メタノールで洗浄して、つい
でメタノールから再結晶すると前記スチリル色素が1g
得られる。That is, first, 2-cyanomethyl-3-
1.2 g of ethylbenzothiazolium iodide and 0.7 g of 4-dimethylaminocinnamaldehyde in 1
Add to 0 ml of acetic anhydride and mix. This mixture is
When heated in a water bath at a temperature of 2 to 3 minutes, acicular crystals precipitate. After heating for 20 minutes, the precipitated needle crystals were separated by suction filtration, washed with methanol, and then recrystallized from methanol to obtain 1 g of the styryl dye.
can get.
【0024】本発明において、電子伝達体としては、メ
ルドラブルー、1−メトキシ−5−メチルフェナジニウ
ムメチルサルフェート(1−mPMS)、ジアホラーゼ
等が挙げられるが、ジアホラーゼが好ましい。In the present invention, examples of the electron carrier include Meldora Blue, 1-methoxy-5-methylphenazinium methyl sulfate (1-mPMS), and diaphorase, with diaphorase being preferred.
【0025】本発明にかかるスチリル色素は、NADH
およびNADPHの合計1モルに対して、好ましくは
0.1〜10.0モル、より好ましくは0.5〜2.0
モル用いればよい。電子伝達体、例えばジアホラーゼ
は、触媒として作用するので、その量は触媒量でよい。
先に述べたように、通常、0.1〜1.0mkat/l
のような割合で用いる。The styryl dye according to the present invention is NADH
And preferably 0.1 to 10.0 moles, more preferably 0.5 to 2.0 moles per mole of NADPH.
It may be used in moles. Since electron carriers such as diaphorase act as catalysts, their amounts may be catalytic.
As mentioned earlier, typically 0.1-1.0 mkat / l
It is used in the ratio as shown below.
【0026】また、本発明の測定用試薬は、前記スチリ
ル色素の選択、例えば前記の式(化1)中のnの選択に
より測定波長を400〜900nmまで任意に選択する
ことが可能である。The measurement reagent of the present invention can arbitrarily select a measurement wavelength from 400 to 900 nm by selecting the styryl dye, for example, selecting n in the above formula (Formula 1).
【0027】その他の測定パラメーターは、主として電
子伝達体によって制約を受けるので、例えば電子伝達体
がジアホラーゼの場合、通常のpHの範囲は5〜9、好
ましくはpH7〜8であり、温度は通常20〜40℃、
好ましくは30〜37℃である。なお、本発明にかかる
スチリル色素は、反応性が高いため、反応に要する時間
は瞬時に近い極めて短い時間である。Since other measurement parameters are mainly restricted by the electron carrier, for example, when the electron carrier is diaphorase, the usual pH range is 5 to 9, preferably pH 7 to 8, and the temperature is usually 20 to 20. ~ 40 ° C,
Preferably it is 30-37 degreeC. Since the styryl dye according to the present invention has high reactivity, the time required for the reaction is an extremely short time that is almost instantaneous.
【0028】本発明が対象とする液体試料は、通常、体
液、例えば血液またはその成分(血漿、血清等)、尿、
髄液または細胞抽出液等であるが、NADHおよびNA
DPHの少なくとも一方を含む液体試料ならいずれも本
発明の対象となる。The liquid sample targeted by the present invention is usually a body fluid such as blood or its components (plasma, serum, etc.), urine,
Cerebrospinal fluid or cell extract, but NADH and NA
Any liquid sample containing at least one of DPH is an object of the present invention.
【0029】これらの試料中に含まれる酵素または酵素
の基質等の成分を測定しようとする場合、その酵素と基
質によって生成する物質を還元酵素及び酸化型ニコチン
アミド補酵素とともに反応させ、生成する還元型ニコチ
ンアミド補酵素の量を本発明の方法により測定する。こ
れにより、目的とする液体試料中の成分の量、濃度を測
定することができる。下記の式(化3)に本発明の測定
用試薬の反応の一例を示す。When it is intended to measure a component such as an enzyme or an enzyme substrate contained in these samples, a substance produced by the enzyme and the substrate is reacted with a reductase and an oxidized nicotinamide coenzyme to produce a reduced enzyme. The amount of type nicotinamide coenzyme is determined by the method of the present invention. Thereby, the amount and concentration of the component in the target liquid sample can be measured. The following formula (Formula 3) shows an example of the reaction of the reagent for measurement of the present invention.
【0030】[0030]
【化3】 Embedded image
【0031】前記の式(化3)の右側の反応式におい
て、ジアホラーゼ(Diaphorase)存在下、N
ADHにより、本発明にかかるスチリル色素(blue
dye)が褪色する(discolor)するととも
に、前記NADHがNADとなる。また、前記の式(化
3)の左側の反応式は、β−ハイドロキシステロイドデ
ヒドロゲナーゼ(β−HSD)の存在下、NADによ
り、3β−ハイドロキシバイル酸が3−オキソステロイ
ドになるとともに、前記NADがNADHとなる。すな
わち、この反応は、NADを補酵素とするβ−HSDの
酵素反応である。したがって、この場合、本発明による
NADHの測定により、β−HSD等の測定が可能とな
る。In the reaction formula on the right side of the above formula (Chem. 3), N in the presence of diaphorase (Diaphorase)
The styryl dye (blue) according to the present invention is produced by ADH.
(dye) is discolored (discolor), and the NADH becomes NAD. In addition, the reaction formula on the left side of the above formula (Formula 3) shows that in the presence of β-hydroxysteroid dehydrogenase (β-HSD), NAD converts 3β-hydroxyvalic acid into a 3-oxosteroid, NADH. That is, this reaction is an enzyme reaction of β-HSD using NAD as a coenzyme. Therefore, in this case, the measurement of β-HSD and the like can be performed by the measurement of NADH according to the present invention.
【0032】この他に、本発明の対象となるのは、例え
ば、α−ハイドロキシステロイドデヒドロゲナーゼ、ア
ルコールデヒドロゲナーゼ、グリセロールデヒドロゲナ
ーゼ、ピルビン酸デヒドロゲナーゼ、グルコースデヒド
ロゲナーゼなどである。Other objects of the present invention are, for example, α-hydroxysteroid dehydrogenase, alcohol dehydrogenase, glycerol dehydrogenase, pyruvate dehydrogenase, glucose dehydrogenase and the like.
【0033】つぎに、本発明の還元型ニコチンアミド補
酵素の測定用試験片に用いる担体としては、例えば、濾
紙、布、不織布、ポリエチレンテレフタレートフィル
ム、ポリエチレンフィルム、ガラス、セラミック等があ
げられ、測定用試験片の種類に応じ適宜選択される。例
えば、測定用試験片を本発明の測定用試薬を担体に含浸
して作製する場合は、吸収可能な担体として濾紙が好適
であり、また、一般的な担体としては、ポリエチレンテ
レフタートフィルムが好適である。The carrier used for the test piece for measuring reduced nicotinamide coenzyme of the present invention includes, for example, filter paper, cloth, nonwoven fabric, polyethylene terephthalate film, polyethylene film, glass, ceramic and the like. Is appropriately selected according to the type of test piece for use. For example, when a test piece for measurement is prepared by impregnating the carrier with the reagent for measurement of the present invention, a filter paper is suitable as an absorbable carrier, and a polyethylene terephthalate film is preferred as a general carrier. It is.
【0034】この測定用試験片を用いた測定方法は、以
下のとおりである。すなわち、まず血液等の液状試料を
前記測定用試験片に付着させる。すると、この試験片が
褪色するので、この褪色程度を分光光度計若しくはデン
シトメーター等で測定することにより、液状試料中のN
ADH等を測定することができる。The measuring method using the test piece for measurement is as follows. That is, first, a liquid sample such as blood is attached to the test piece for measurement. Then, since the test piece fades, the degree of the fading is measured by a spectrophotometer or a densitometer or the like, whereby the N in the liquid sample is measured.
ADH and the like can be measured.
【0035】[0035]
【実施例】つぎに、実施例について説明する。実施例に
用いるスチリル色素として、前記の式(化2)で表され
る2−[1−シアノ−4−(4−ジメチルアミノフェニ
ル)−1,3−ブタジエニル]−3−エチルベンゾチア
ゾリウム アイオダイドを用いた。以下に、反応液組成
および測定用検体(液状試料)を示す。なお、下記の反
応液および測定用検体の組成は、全て最終濃度を示す。Next, an embodiment will be described. As a styryl dye used in Examples, 2- [1-cyano-4- (4-dimethylaminophenyl) -1,3-butadienyl] -3-ethylbenzothiazolium represented by the above formula (Formula 2) is used. Iodide was used. The composition of the reaction solution and the measurement sample (liquid sample) are shown below. The compositions of the following reaction solutions and measurement samples all indicate final concentrations.
【0036】(実施例1) 反応液組成 色素 0.05mmol/L ジアホラーゼ 0.83mkat/L Tris−HCl(pH8.0) 0.20 mol/L 測定用検体 β−NADH 0〜50μmol/L (実施例2) 反応液組成 色素 0.05mmol/L ジアホラーゼ 0.83mkat/L Tris−HCl(pH8.0) 0.20 mol/L 測定用検体 β−NADH 0〜50μmol/L アスコルビン酸 1.0g/L つぎに、実施例1、2において、以下の手順で測定を行
い検量線を作成した。 (1)反応セルにTris−HCl緩衝液を入れる。こ
の量は、実施例1では2.65mlであり、実施例2で
は2.55mlである。 (2)色素液0.1ml、ジアホラーゼ0.15mlを
反応セルに加えて攪拌した後、25℃で5分インキュベ
ートする。 (3)各濃度の検体を、実施例1では0.1ml、実施
例2では0.2ml、反応セルに加え、攪拌後、直ちに
640nmにおける吸光度を測定し、検量線を作成す
る。Example 1 Composition of Reaction Solution Dye 0.05 mmol / L Diaphorase 0.83 mkat / L Tris-HCl (pH 8.0) 0.20 mol / L Specimen for Measurement β-NADH 0 to 50 μmol / L Example 2) Composition of reaction solution Dye 0.05 mmol / L Diaphorase 0.83 mkat / L Tris-HCl (pH 8.0) 0.20 mol / L Sample for measurement β-NADH 0 to 50 μmol / L Ascorbic acid 1.0 g / L Next, in Examples 1 and 2, measurement was performed according to the following procedure to prepare a calibration curve. (1) Add Tris-HCl buffer to the reaction cell. This amount is 2.65 ml in Example 1 and 2.55 ml in Example 2. (2) 0.1 ml of the dye solution and 0.15 ml of diaphorase are added to the reaction cell, stirred, and incubated at 25 ° C. for 5 minutes. (3) Add 0.1 ml of each concentration of the sample to the reaction cell in Example 1 and 0.2 ml in Example 2, and measure the absorbance at 640 nm immediately after stirring to prepare a calibration curve.
【0037】実施例1の検量線を図1のグラフに、実施
例2の検量線を図2のグラフに示す。このように、本発
明の実施例では、反応後、直ちに測定に供することがで
きるため、迅速な測定が可能であった。また、実施例2
の結果より、還元物質であるアスコルビン酸が共存して
いても、この影響を受けることなくNADHの測定が可
能であるといえる。The calibration curve of Example 1 is shown in the graph of FIG. 1, and the calibration curve of Example 2 is shown in the graph of FIG. As described above, in the examples of the present invention, measurement can be performed immediately after the reaction, so that quick measurement was possible. Example 2
From the results, it can be said that even when ascorbic acid as a reducing substance coexists, NADH can be measured without being affected by this.
【0038】(実施例3)下記の組成の含浸液を調製
し、これを10×10cmの濾紙(Whatman社
製、3MM,Chr)に含浸し、ついで乾燥機(YAM
ATO社製、DF62)を用い50℃、15分間の条件
で乾燥させた。そして、この濾紙を、幅5mmに裁断
し、両面テープを用いてポリエチレンテレフタレートフ
ィルムに貼着し、さらにこれを5mmに裁断し5×5m
mの測定用試験片を作製した。Example 3 An impregnating solution having the following composition was prepared and impregnated with a filter paper (3MM, Chr, Whatman) having a size of 10 × 10 cm, and then dried (YAM).
It was dried at 50 ° C. for 15 minutes using DF62 (ATO). Then, this filter paper is cut into a width of 5 mm, and is adhered to a polyethylene terephthalate film using a double-sided tape.
A test piece for measuring m was prepared.
【0039】 含浸液組成 色素 0.05mmol/L ジアフォラーゼ 0.83mkat/L Tris−HCl(pH7.2) 0.2mol/L 他方、測定試料として、4種類の濃度のNADH水溶液
(濃度:0μmol/L,20μmol/L,50μm
ol/L,100μmol/L)を準備した。Impregnating Solution Composition Dye 0.05 mmol / L Diaphorase 0.83 mkat / L Tris-HCl (pH 7.2) 0.2 mol / L On the other hand, four types of NADH aqueous solutions (concentration: 0 μmol / L) were used as measurement samples. , 20 μmol / L, 50 μm
ol / L, 100 μmol / L).
【0040】そして、前記試験片に点着量8μlで上記
NADH水溶液を点着し、色差計(Σ90、日本電色社
製)を用い、測定時間120秒(エンドポイント)およ
び測定温度25℃の条件で640nmでの反射率を測定
した。この測定結果を、図3のグラフに示す。Then, the above NADH aqueous solution was spotted on the test piece at a spotting amount of 8 μl, and a measuring time of 120 seconds (end point) and a measuring temperature of 25 ° C. were measured using a color difference meter (# 90, manufactured by Nippon Denshoku). Under the conditions, the reflectance at 640 nm was measured. The measurement results are shown in the graph of FIG.
【0041】同図に示すように、NADHの濃度に対応
する検量線が得られた。また、この実施例は、乾式測定
の実施例であるが、測定において高い反応性を確認する
ことができた。As shown in the figure, a calibration curve corresponding to the concentration of NADH was obtained. In addition, this example is an example of dry measurement, and high reactivity was confirmed in the measurement.
【0042】[0042]
【発明の効果】以上のように、本発明の還元型ニコチン
アミド補酵素の測定用試薬は、前記の式[化1]で示さ
れるスチリル色素を含有する。この特殊なスチリル色素
は、電子伝達体の存在下で、NADHおよびNADPH
の少なくとも一方と作用させると、高い選択性でNAD
H等を測定できる。しかも、この測定では、紫外部に蛍
光等を有する共存物質およびアスコルビン酸、ビリルビ
ン等の影響を受けない。このため、本発明の測定用試薬
を用いれば、前処理等をせずに、高い精度で簡単に試料
中のNADH等を測定できる。また、この特殊なスチリ
ル色素は、乾式測定に供しても高い反応性を失うことが
ないため、これを用いれば、測定用試験片を作成するこ
とが可能となる。この測定用試験片を用いることによ
り、NADH等の測定がさらに容易となる。As described above, the reagent for measuring reduced nicotinamide coenzyme of the present invention contains the styryl dye represented by the above formula [Formula 1]. This particular styryl dye, in the presence of an electron carrier, NADH and NADPH
NAD with high selectivity
H etc. can be measured. Moreover, this measurement is not affected by coexisting substances having fluorescence or the like in the ultraviolet, ascorbic acid, bilirubin, and the like. Therefore, by using the measuring reagent of the present invention, NADH or the like in a sample can be easily measured with high accuracy without performing pretreatment or the like. In addition, since this special styryl dye does not lose high reactivity even when subjected to dry measurement, a test piece for measurement can be prepared by using this. By using this test piece for measurement, measurement of NADH and the like is further facilitated.
【図1】本発明の一実施例におけるNADHの検量線を
示すグラフである。FIG. 1 is a graph showing a calibration curve of NADH in one example of the present invention.
【図2】本発明のその他の実施例におけるNADHの検
量線を示すグラフである。FIG. 2 is a graph showing a calibration curve of NADH in another example of the present invention.
【図3】本発明のさらにその他の実施例におけるNAD
Hの検量線を示すグラフである。FIG. 3 shows a NAD according to still another embodiment of the present invention.
It is a graph which shows the calibration curve of H.
Claims (10)
素を含有する還元型ニコチンアミド補酵素の測定用試
薬。 【化1】 1. A reagent for measuring reduced nicotinamide coenzyme containing a styryl dye represented by the following formula [Chemical Formula 1]. Embedded image
元型ニコチンアミド補酵素の測定用試薬。2. The reagent for measuring reduced nicotinamide coenzyme according to claim 1, which comprises an electron mediator.
項1または2記載の還元型ニコチンアミド補酵素の測定
用試薬。3. The reagent for measuring reduced nicotinamide coenzyme according to claim 1, wherein the electron carrier is diaphorase.
ニコチンアミドアデニンジヌクレオチドおよび還元型ニ
コチンアミドアデニンジヌクレオチドホスフェートの少
なくとも一方の補酵素である請求項1〜3のいずれか一
項に記載の還元型ニコチンアミド補酵素の測定用試薬。4. The reduced nicotinamide adenine dinucleotide and / or reduced nicotinamide adenine dinucleotide phosphate coenzyme according to claim 1, wherein the reduced nicotinamide coenzyme is a coenzyme of at least one of reduced nicotinamide adenine dinucleotide and reduced nicotinamide adenine dinucleotide phosphate. Reagent for measuring reduced nicotinamide coenzyme.
還元型ニコチンアミド補酵素の測定用試薬中のスチリル
色素と液体試料に含まれる還元型ニコチンアミド補酵素
とを反応させて前記スチリル色素を褪色させ、可視部の
吸光度の変化を測定する還元型ニコチンアミド補酵素の
測定方法。5. A reaction between a styryl dye in the reagent for measuring reduced nicotinamide coenzyme according to claim 1 and a reduced nicotinamide coenzyme contained in a liquid sample in the presence of an electron carrier. A method for measuring reduced nicotinamide coenzyme, in which a styryl dye is faded and the change in absorbance in the visible region is measured.
ル、胸水、腹水、汗、涙または唾液である請求項5に記
載の還元型ニコチンアミド補酵素の測定方法。6. The method for measuring reduced nicotinamide coenzyme according to claim 5, wherein the liquid sample is blood, urine, bone marrow fluid, recall, pleural effusion, ascites, sweat, tears or saliva.
請求項5または6記載の還元型ニコチンアミド補酵素の
測定方法。7. The method for measuring reduced nicotinamide coenzyme according to claim 5, wherein diaphorase is used as the electron carrier.
対しジアホラーゼ0.12〜1.20mkatの割合で
ある請求項7記載の還元型ニコチンアミド補酵素の測定
方法。8. The method for measuring reduced nicotinamide coenzyme according to claim 7, wherein the ratio of diaphorase is 0.12 to 1.20 mkat with respect to 0.1 to 10.0 mol of the styryl dye.
ニコチンアミドアデニンジヌクレオチドおよび還元型ニ
コチンアミドアデニンジヌクレオチドホスフェートの少
なくとも一方の補酵素である請求項5〜8のいずれか一
項に記載の還元型ニコチンアミド補酵素の測定方法。9. The reduced nicotinamide adenine dinucleotide and / or reduced nicotinamide adenine dinucleotide phosphate coenzyme according to any one of claims 5 to 8, wherein the reduced nicotinamide coenzyme is a coenzyme of at least one of reduced nicotinamide adenine dinucleotide and reduced nicotinamide adenine dinucleotide phosphate. Method for measuring reduced nicotinamide coenzyme.
ド補酵素の測定用試薬を担体に付着させた還元型ニコチ
ンアミド補酵素の測定用試験片。10. A test piece for measuring reduced nicotinamide coenzyme, wherein the reagent for measuring reduced nicotinamide coenzyme according to claim 2 is attached to a carrier.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP18497796A JP3889834B2 (en) | 1996-07-15 | 1996-07-15 | Reagent for measuring reduced nicotinamide coenzyme, measurement method using the same, and test specimen for measurement |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP18497796A JP3889834B2 (en) | 1996-07-15 | 1996-07-15 | Reagent for measuring reduced nicotinamide coenzyme, measurement method using the same, and test specimen for measurement |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH1031018A true JPH1031018A (en) | 1998-02-03 |
| JP3889834B2 JP3889834B2 (en) | 2007-03-07 |
Family
ID=16162655
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP18497796A Expired - Lifetime JP3889834B2 (en) | 1996-07-15 | 1996-07-15 | Reagent for measuring reduced nicotinamide coenzyme, measurement method using the same, and test specimen for measurement |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3889834B2 (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007240528A (en) * | 2006-02-10 | 2007-09-20 | Canon Inc | Information acquisition device for concentration of thioredoxins in sample, stress level information acquisition device, and stress level determination method |
| CN105985771A (en) * | 2015-11-10 | 2016-10-05 | 济南大学 | Method and kit for detecting divalent iron ions |
| CN105985299A (en) * | 2015-11-10 | 2016-10-05 | 济南大学 | Fluorescent probe capable of analyzing ferrous ions in highly-selective and ultrasensitive manner |
| JP2017530098A (en) * | 2014-08-22 | 2017-10-12 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | Redox indicator |
| CN117263928A (en) * | 2023-09-20 | 2023-12-22 | 南通大学 | A kind of fluorescent probe and its preparation method |
-
1996
- 1996-07-15 JP JP18497796A patent/JP3889834B2/en not_active Expired - Lifetime
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007240528A (en) * | 2006-02-10 | 2007-09-20 | Canon Inc | Information acquisition device for concentration of thioredoxins in sample, stress level information acquisition device, and stress level determination method |
| JP2017530098A (en) * | 2014-08-22 | 2017-10-12 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | Redox indicator |
| JP2020073590A (en) * | 2014-08-22 | 2020-05-14 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | Redox indicator |
| CN111848578A (en) * | 2014-08-22 | 2020-10-30 | 豪夫迈·罗氏有限公司 | redox indicator |
| EP3757096A1 (en) * | 2014-08-22 | 2020-12-30 | Roche Diagnostics GmbH | Redoxindicators |
| CN111848578B (en) * | 2014-08-22 | 2023-10-31 | 豪夫迈·罗氏有限公司 | redox indicator |
| CN105985771A (en) * | 2015-11-10 | 2016-10-05 | 济南大学 | Method and kit for detecting divalent iron ions |
| CN105985299A (en) * | 2015-11-10 | 2016-10-05 | 济南大学 | Fluorescent probe capable of analyzing ferrous ions in highly-selective and ultrasensitive manner |
| CN105985771B (en) * | 2015-11-10 | 2018-04-03 | 济南大学 | Detect the method and its kit of ferrous ion |
| CN117263928A (en) * | 2023-09-20 | 2023-12-22 | 南通大学 | A kind of fluorescent probe and its preparation method |
Also Published As
| Publication number | Publication date |
|---|---|
| JP3889834B2 (en) | 2007-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2015513C1 (en) | Agent for colorimetric determination of analyte | |
| US4066403A (en) | Multilayer analytical element | |
| JP7181242B2 (en) | redox indicator | |
| RU2114914C1 (en) | Method, means, test system for colorimetric determination of test solution, and nitrosoaniline compounds | |
| EP0383092B1 (en) | Chromogenic merocyanine enzyme substrates | |
| US20090233322A1 (en) | Colorimetric method and reagent used for the same | |
| JPH10130247A (en) | Redox active compounds and uses thereof | |
| AU592440B2 (en) | New derivatives as redox indicators, and the use thereof | |
| JPH1031018A (en) | Reduced form nicotinamide coenzyme measuring reagent and measuring method and measuring test piece using it | |
| US4824779A (en) | Method for the determination of the reduced form of nicotinamide adenine dinucleotide | |
| PL214277B1 (en) | Method of colorimetry and reagent for use therein | |
| CA2049230C (en) | 2-benzothiazolyl tetrazolium salt indicators | |
| JPH0532040B2 (en) | ||
| JPH01128797A (en) | Method for quantitative determination of compound | |
| US5300637A (en) | 2-benzothiazolyl tetrazolium salt indicators | |
| JPH09121892A (en) | Reagent for determining reduced type nicotinamide coenzyme and its determination | |
| JPS63100376A (en) | Composition and method using substituted orthoquinones as electron transfer agent in analysis and measurement | |
| JPS6367570A (en) | Method of measuring analytical composition, analytical element and article to be analyzed | |
| JP4001953B2 (en) | Analytical elements and methods for measuring acetaminophen | |
| US5290536A (en) | Phenyl substituted 2-thiazolyl tetrazolium salt indicators | |
| CA2049209C (en) | Phenyl-substituted 2-thiazolyl tetrazolium salt indicators | |
| JPS62285799A (en) | Measurement of component contained in humor and reagent used therefor | |
| JPS59106476A (en) | Water-soluble tetrazolium compound and a method for determining reductive substance using the same | |
| JPH03282259A (en) | Composition for measuring peroxide active material based on redox reaction and test piece using the composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A132 Effective date: 20060413 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060608 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060808 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060817 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20061116 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20061201 |
|
| R150 | Certificate of patent (=grant) or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091208 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101208 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101208 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111208 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111208 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121208 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121208 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131208 Year of fee payment: 7 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |